[go: up one dir, main page]

AU7514087A - Vaccine containing the protein f of the aids virus - Google Patents

Vaccine containing the protein f of the aids virus

Info

Publication number
AU7514087A
AU7514087A AU75140/87A AU7514087A AU7514087A AU 7514087 A AU7514087 A AU 7514087A AU 75140/87 A AU75140/87 A AU 75140/87A AU 7514087 A AU7514087 A AU 7514087A AU 7514087 A AU7514087 A AU 7514087A
Authority
AU
Australia
Prior art keywords
protein
vaccine containing
aids virus
aids
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU75140/87A
Other versions
AU614934B2 (en
Inventor
Bruno Guy
Marie-Paule Kieny
Jean-Pierre Lecocq
Luc Montagnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Institut Pasteur
Original Assignee
Transgene SA
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA, Institut Pasteur filed Critical Transgene SA
Publication of AU7514087A publication Critical patent/AU7514087A/en
Application granted granted Critical
Publication of AU614934B2 publication Critical patent/AU614934B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
    • C07K16/1054—Lentiviridae, e.g. HIV, FIV, SIV gag-pol, e.g. p17, p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • AIDS & HIV (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Viral vector characterized in that it comprises at least one portion of the genome of a virus, a gene coding for the protein F of the virus responsible for AIDS, as well as the elements providing for the expression of said protein in cells. Said viral vector may be used as vaccine in the treatment, prevention and diagnosis of AIDS.
AU75140/87A 1986-06-16 1987-06-15 Vaccine containing the protein f of the aids virus Ceased AU614934B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8608698A FR2600079B1 (en) 1986-06-16 1986-06-16 VIRAL VECTOR AND RECOMBINANT DNA ENCODING PROTEIN F OF THE VIRUS CAUSAL AGENT OF THE S.I.D.A, CELL CULTURE INFECTED WITH THIS VECTOR, PROCESS FOR PREPARING THE PROTEIN, OBTAINED PROTEIN, VACCINE AND ANTIBODIES OBTAINED
FR8608698 1986-06-16

Publications (2)

Publication Number Publication Date
AU7514087A true AU7514087A (en) 1988-01-11
AU614934B2 AU614934B2 (en) 1991-09-19

Family

ID=9336386

Family Applications (1)

Application Number Title Priority Date Filing Date
AU75140/87A Ceased AU614934B2 (en) 1986-06-16 1987-06-15 Vaccine containing the protein f of the aids virus

Country Status (11)

Country Link
EP (1) EP0253693B1 (en)
JP (1) JPH01500962A (en)
KR (1) KR880701285A (en)
AT (1) ATE103980T1 (en)
AU (1) AU614934B2 (en)
DE (1) DE3789525T2 (en)
DK (1) DK76688A (en)
ES (1) ES2062990T3 (en)
FR (1) FR2600079B1 (en)
PT (1) PT85093B (en)
WO (1) WO1987007642A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2615623B1 (en) * 1987-05-22 1992-06-19 Transgene Sa AIDS DIAGNOSIS TEST BASED ON THE EVIDENCE OF A DIVERSITY OF ISOTYPIC RESPONSE, VACCINES AND SEROTHERAPIES
FR2620030B1 (en) * 1987-09-07 1990-03-23 Transgene Sa VECTOR FOR THE EXPRESSION OF PROTEINS OF HIV-2 VIRUS, A CAUSAL AGENT FOR AIDS, CELL CULTURE INFECTED OR TRANSFORMED THROUGH THIS VECTOR, PROTEINS OBTAINED, VACCINE AND ANTIBODIES OBTAINED
FR2629459B1 (en) * 1988-04-01 1990-12-21 Pasteur Institut PEPTIDES PF11 TO PF19 OF AN HIV RETROVIRUS - PROCESS FOR THE SYNTHESIS OF THESE PEPTIDES - THEIR USE IN PARTICULAR FOR DIAGNOSIS
JPH03503639A (en) * 1988-04-01 1991-08-15 アンステイテユ・パストウール Peptides PF10 to PF19 of retrovirus HIV, methods for the synthesis of said peptides, especially their use for diagnostic purposes
FR2629460B1 (en) * 1988-04-01 1990-12-21 Pasteur Institut PF16 PEPTIDES OF A HIV RETROVIRUS - PROCESS FOR THE SYNTHESIS OF THESE PEPTIDES - THEIR USE FOR DIAGNOSIS
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
BR9007566A (en) * 1990-05-28 1992-06-30 Univ Osaka Res Found METHOD OF PREPARING PLASMIDE, PLASMIDE AND PLASMIDE EXPRESSION PRODUCTS
FR2766091A1 (en) * 1997-07-18 1999-01-22 Transgene Sa ANTITUMOR COMPOSITION BASED ON MODIFIED IMMUNOGENIC POLYPEPTIDE WITH CELL LOCATION

Also Published As

Publication number Publication date
PT85093B (en) 1990-03-30
AU614934B2 (en) 1991-09-19
DK76688D0 (en) 1988-02-15
DE3789525D1 (en) 1994-05-11
KR880701285A (en) 1988-07-26
DE3789525T2 (en) 1994-08-25
JPH01500962A (en) 1989-04-06
DK76688A (en) 1988-02-15
ATE103980T1 (en) 1994-04-15
FR2600079B1 (en) 1989-10-20
FR2600079A1 (en) 1987-12-18
ES2062990T3 (en) 1995-01-01
EP0253693A1 (en) 1988-01-20
EP0253693B1 (en) 1994-04-06
WO1987007642A1 (en) 1987-12-17
PT85093A (en) 1987-07-01

Similar Documents

Publication Publication Date Title
AU3636189A (en) Hiv-2 virus variants
CA2011878A1 (en) Immunogenic regions on the e7 protein of human papillomavirus type 16
GR3034708T3 (en) Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof.
GB2303854B (en) Helicobacter proteins and vaccines
CZ63995A3 (en) Virus vectors and their use in gene therapy
EP0256092A4 (en) Attenuated herpesviruses, herpesviruses which include foreign dna encoding an amino acid sequence and vaccine containing same.
CA2243570A1 (en) Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv
CA2186044A1 (en) Novel mutated viruses, anti-viral compounds and novel methods of making vaccines
AU7234987A (en) Viral vector coding for a glycoprotein of the virus responsible for a.i.d.s., vaccine and antibody
AU3904685A (en) Cloning of dna for protozoal antigens
EP0306219A3 (en) Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
AU7514087A (en) Vaccine containing the protein f of the aids virus
ATE310828T1 (en) IMPLANT AND VECTOR FOR THE TREATMENT OF ACQUIRED DISEASES
AU2833789A (en) Non-reverting rna viruses
AU2520692A (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus
AU7890687A (en) DNA sequence vectors, recombinant viruses and method which employs recombinant vaccinia viruses capable of multiplying in CHO cells
AU3929589A (en) Human papilloma virus type 57, the dna thereof and the proteins encoded thereby
EP0276591A3 (en) Viral vector and recombinant dna coding for the p25 protein of the aids virus
AU630099B2 (en) Non-reverting rna viruses
FR2720756B1 (en) Recombinant viruses, preparation and use in gene therapy.
AU2715288A (en) Human respiratory syncytialvirus vaccine derived from the 1a (9.5 kd) protein
EP0288901A3 (en) Recombinant human glutathione peroxidase, process for preparing the same and dna coding the same